Medicine & Life Sciences
Cryptococcus gattii
100%
Cryptococcus neoformans
73%
Cryptococcosis
62%
Cryptococcus
44%
Colombia
43%
Multilocus Sequence Typing
32%
Mycoses
27%
Fluconazole
25%
Serogroup
22%
Virulence
21%
Candida
21%
Infections
20%
Genetic Variation
20%
Latin America
15%
Molecular Epidemiology
13%
Candida albicans
13%
HIV
12%
Genotype
12%
Peptides
11%
Peru
10%
Yeasts
10%
Cryptococcal Meningitis
10%
Epidemiology
9%
Flucytosine
9%
Voriconazole
9%
Azoles
8%
Immunoglobulin G
8%
Restriction Fragment Length Polymorphisms
8%
Fungemia
7%
Streptococcus pneumoniae
7%
Disease Outbreaks
7%
Mass Spectrometry
7%
Invasive Candidiasis
7%
Meningoencephalitis
7%
Antigens
7%
Transplant Recipients
6%
Candida parapsilosis
6%
North America
6%
Clone Cells
6%
Genome
6%
Population
6%
Polymerase Chain Reaction
6%
Lasers
6%
Guatemala
6%
Larva
5%
Northwestern United States
5%
Lanosterol
5%
Scedosporium
5%
Population Genetics
5%
Lung
5%
Agriculture & Biology
Cryptococcus gattii
39%
Cryptococcus neoformans
30%
cryptococcosis
25%
Cryptococcus (Tremellomycetes)
17%
mycoses
14%
Latin America
14%
molecular epidemiology
13%
multilocus sequence typing
12%
candidiasis
10%
genetic variation
10%
infection
10%
virulence
9%
fluconazole
9%
Colombia
9%
Candida
8%
yeasts
7%
azoles
6%
Galleria mellonella
6%
therapeutics
5%
lanosterol
5%
meningoencephalitis
5%
aspergillosis
5%
genotype
5%